Cary Street Partners Investment Advisory’s Prothena Corp PRTA Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$754	Buy	+77	New	+$760	﹤0.01%	745

Other funds holding PRTA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Cary Street Partners Investment Advisory's PRTA Position: Q2 2026 in Review

Cary Street Partners Investment Advisory opened a new position in Prothena Corp (PRTA) in Q2 2026: 77 shares worth $754. The stake represents ﹤0.01% of the portfolio and ranks #745 among its holdings.

85 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

Cary Street Partners Investment Advisory held 77 shares of Prothena Corp worth $754 as of Q2 2026.
Prothena Corp was a new Cary Street Partners Investment Advisory position in Q2 2026.
Prothena Corp made up ﹤0.01% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #745 holding.
85 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.